Sociedad Americana de Hirudoterapia

Use of expanded reverse sural artery flap in lower extremity reconstruction

Research article published in Journal of foot and ankle surgery (2011)

Última actualización: June 18, 2026Revisado por: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Observational studyEnsayos clínicosKose AA et al. · Journal of foot and ankle surgery, 2011

Abstract

Coverage of defects of the distal third portion of the leg and foot remains a challenge for surgeons. The difficulty results from the limited mobility and availability of the overlying skin, the weight-bearing requirements, and the relatively poor circulation of the skin. From January 2008 to December 2009, 10 patients had defects of the foot and ankle covered using the 2-stage expanded reverse sural flap. Of these 10 patients, 6 had at least 1 risk factor for compromised wound healing, such as diabetes mellitus, peripheral arterial disease, venous insufficiency, tobacco smoking, or age older than 40 years. Flap necrosis was observed in only 1 patient (10%). Venous congestion was noted in 2 patients (20%) by the third postoperative day, 1 of whom responded to postural elevation of the extremity and 1 to medicinal leech therapy. Although it is a 2-stage procedure that requires wound dressing during the expansion, we strongly suggest the use of the expanded reverse sural flap for defects too large to be primarily closed, especially in patients older than 40 years with risk factors such as diabetes mellitus, peripheral arterial disease, or venous insufficiency.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeComparative StudyJournal Article
Indexed MeSH termsAdolescentAdultAgedArteriesChildFemaleFollow-Up StudiesFoot InjuriesGraft SurvivalHumansLeg InjuriesMale

Resumen

Use of expanded reverse sural artery flap in lower extremity reconstruction.

Por qué esto importa para la hirudoterapia

The article reports a two-stage expanded reverse sural flap technique for covering distal leg and foot defects in 10 patients, six of whom had at least one risk factor for compromised wound healing. Flap necrosis occurred in one patient (10%), and venous congestion was noted in two patients (20%) by the third postoperative day; one responded to postural elevation and one responded to medicinal leech therapy. This is relevant to ASH's domain because the abstract explicitly documents medicinal leech therapy as a clinical intervention used for venous congestion in a reconstructive flap. The caveat is that leech therapy is mentioned only for one patient, without species, protocol, duration, or outcome detail beyond 'responded to'; the study's main focus is flap technique rather than hirudotherapy.

Citación

Use of expanded reverse sural artery flap in lower extremity reconstruction

Kose AA et al. · Journal of foot and ankle surgery, 2011

Contexto clínico relacionado

Añadido a la biblioteca ASH: May 27, 2026 · Última actualización del sitio: June 18, 2026

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.